Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir

Criteria

Inclusion Criteria:

• Type 1 or type 2 diabetes mellitus

Exclusion Criteria:

• Subjects who are unlikely to comply with the protocol

• Subjects who are currently being treated with Levemir®

• Subjects who previously were enrolled into the study

• Subjects with hypersensitivity to Levemir® or any of its excipients